Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04256512 · ClinicalTrials.gov registry record · NA
Cryotherapy for the Prevention of Taxane-Induced Sensory Neuropathy of the Hands and Feet in Breast Cancer Patients
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 94
- Enrollment target
NCT04256512: Completed NA study, sponsored by Mayo Clinic.
NCT04256512 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 94 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04256512, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 94 participants
- Enrollment target
Study Summary
This clinical trial investigates the effect and tolerability of cryotherapy and to evaluate whether they can prevent or improve taxane-induced sensory peripheral neuropathy in breast cancer patients. Cryosurgery, also known as cryoablation or cryotherapy, kills tumor cells by freezing them. Patients receiving cryotherapy during infusion of taxane therapy may have lower incidence of peripheral neuropathy, better physical function, and higher quality of life as compared to patients previously reported in literature.
Interventions
- OTHER Questionnaire Administration
- DEVICE Medical Device Usage and Evaluation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2020-03-10 |
| Est. Completion | 2023-01-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04256512
The ClinicalTrials.gov registry entry for NCT04256512 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire Administration is the first listed.
NCT04256512 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04256512 about?
NCT04256512 is a clinical study titled "Cryotherapy for the Prevention of Taxane-Induced Sensory Neuropathy of the Hands and Feet in Breast Cancer Patients". This clinical trial investigates the effect and tolerability of cryotherapy and to evaluate whether they can prevent or improve taxane-induced sensory peripheral neuropathy in breast cancer patients. Cryosurgery, also known as cryoablation or cryotherapy, kills tumor cells by freezing them. Patients...
What is the current status of trial NCT04256512?
This trial is currently completed. It is a NA study. The enrollment target is 94 participants. The study started on 2020-03-10. Estimated completion is 2023-01-18.
What interventions are being tested in trial NCT04256512?
The interventions under investigation include: Questionnaire Administration (OTHER), Medical Device Usage and Evaluation (DEVICE).
Who is sponsoring clinical trial NCT04256512?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.